Acetaldehyde Diethyl Acetal CAS 3616-56-6 Puritas >99.0% (GC) Afatinib Dimaleate Intermedia Factory

Description:

Nomen: (Dimethylamino) acetaldehyde Diethyl acetal

Synonyma: 2,2-Diethoxy-N,N-Dimethylethylamine

CAS: 3616-56-6

Puritas: >99.0% (GC)

Aspectus: Hyalina Liquidum Serenum

Afatinib Dimaleate (CAS: 850140-73-7)

High Quality, Commercial Production

E-Mail: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Descriptio:

Chemical Properties:

Nomen chemicum (Dimethylamino) acetaldehyde Diethyl acetal
Synonyma 2,2-Diethoxy-N,N-Dimethylethylamine;N-(2,2-Diethoxyethyl)dimethylamine;2,2-Diethoxy-N,N-Dimethylethan-1-Amine
CAS Number 3616-56-6
CATTUS Number RF-PI2031
Stock Status In Stock, Productio Ascendite ad Tons
Formulae hypotheticae C8H19NO2
M. Pondus 161.25
Sensibilitas umorem Sensitivum
Ferveret 60℃/5 mmHg
Mico punctum 45℃
Brand Ruifu Chemical

Specifications:

Item Specifications
Aspectus Hyalina liquida
Puritas / Analysis Methodus >99.0% (GC)
Index refractivus N20/D 1.410~1.414
Gravitas Imprimis (20/20℃) 0.865~0.870
Proton NMR Spectrum Conformat ut Structure
Totalis immunditias <1.00%
Metalla gravia (ut Pb) ≤20ppm
Test Standard Enterprise Standard
Consuetudinem Pharmaceutical Intermedia;Afatinib Dimaleate;Sumatriptan

Sarcina & Repono:

sarcina: Fluorinated Utrem, 25kg/Drum, vel secundum exigentiam mos

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore

commoda:

1

FAQ:

Applicatio:

acetaldehyda Diethyl acetalis (CAS: 3616-56-6) adhibetur pro intermediis pharmaceuticis.acetaldehyde Diethyl acetal in synthesi Afatinib Dimaleate (CAS: 850140-73-7), Sumatriptan (CAS: 103628-46-2).Afatinib (nomen artis Gilotrif in US et Giotrif in Europa, antea Tomtovok et Tovok) medicamentum probatum est in Civitatibus Foederatis, Europa, Taiwan, Mexici, Chile et Iaponia necnon in aliis regionibus ad curationem primi-lineae aegris distinctis. genera metastaticae (EGFR mutationis positivae) non parvae cellae pulmonis carcinomatis (NSCLC), a Boehringer Ingelheim evoluta.Afatinib agit inhibitor irreversibilis covalentoris tyrosini kinases epidermalis receptantis aucti (EGFR) et erbB-2 (HER2).Sumatriptan primus triptanus probatus est (1991) pro theacutis curatione capitis cephalea.Bioavailbilitatem infima inter omnes triptans habet propter humilitatem suam.Praeparatio plurium dosagenarum variarum (ie, tabulae oralis, iniectio SC, formulae nasi imbre, et suppositorium) flexibilitatem tailoringtherapiae ad necessitates singulorum aegrorum permittit, ita sumatriptans medicamentum valde utilem faciens ad acutum cephalaeum curationi. capitis doloribus.Sumatriptan quoque modum fastigium actionis per SC iniectionem vel imbrem nasi administrationis habet.

Epistulam tuam hic scribe et mitte nobis